Related Experiment Video
Updated: Sep 21, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
The dilemma for women of color in clinical trials
1Department of Obstetrics and Gynecology, New York University Medical Center, New York City.
Abstract:
Women in general and women of color in particular have been noticeably absent from clinical research, be it phase I pharmacokinetic drug trials or natural history observational studies. This paper examines several questions about the role of women of color in clinical research: Who participates in clinical trials and why? Do women of color face a particular dilemma in deciding to participate? A biologic construct for race and gender research issues is presented. Given the variations of pharmacokinetics and pharmacodynamics that may be race- or gender-related, certain obstacles must be addressed in order to facilitate responsible research. Those obstacles include the history of abuse of vulnerable populations in the name of clinical research, discrimination in medical care, and the lack of understanding of the combined impact of gender, race, ethnicity, and class on behavior and health.
Related Concept Videos
Ethics in Research
Clinical Trials
There are four phases in a clinical trial. A phase one...
Blinding
Clinical Trials: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioequivalence studies: Biowaivers

